Conference Chair

Christopher M. Mikson

Partner at Mayer Brown LLP

Speakers

Ginny Beakes-Read

Executive Director/Special Counsel, Regulatory Strategy and Law at Eisai Inc.

Ryan P. Blaney

Member at Cozen O’Connor

Drugs and Biologics: Labeling

September 14, 2017 1:45 pm

Robert E. Johnston

Partner at Hollingsworth LLP

Amy Judge-Prein

Partner at Faegre Baker Daniels LLP

Kurt R. Karst

Director at Hyman, Phelps & McNamara, P.C.

PART 2: Hatch-Waxman and BPCIA Overview

September 14, 2017 3:30 pm

Scott Lassman

Partner at Goodwin Procter LLP

Andrea Masciale

Vice President, Regulatory Policy & Global Analytics at Johnson & Johnson Worldwide Government Affairs & Policy

Gary C. Messplay

Partner at King & Spalding

Donna M. Meuth

Associate General Counsel, Intellectual Property at Eisai Inc.

Joseph G. Poluka

Partner at Blank & Rome LLP

Deborah M. Shelton

Partner, Leader of the Food & Drug Law Practice at McCarter & English, LLP

Brian Walsh

Assistant General Counsel – Intellectual Property at Bristol-Myers Squibb

Drugs and Biologics: Labeling

September 14, 2017 1:45 pm

Michael A. Walsh

Partner at Strasburger & Price, L.L.P.

Donald R. Ware

Partner and Chair of Intellectual Property Department at Foley Hoag LLP

PART 2: Hatch-Waxman and BPCIA Overview

September 14, 2017 3:30 pm